1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Belgium Pharmaceuticals and Healthcare Report Q1 2016

Belgium Pharmaceuticals and Healthcare Report Q1 2016

  • December 2015
  • -
  • Business Monitor International
  • -
  • 80 pages

Includes 3 FREE quarterly updates

BMI View: Governments in developed states such as Belgium will need to work to maintain the countries'long-term attractiveness as sites for clinical trials, especially as the cost of conducting clinical research isforecast to rise. An increasing number of clinical trials are being conducted in emerging markets, mainlydue to lower costs. The attractiveness of these non-traditional destinations is boosted by improvinghealthcare infrastructure, more and better trained medical professionals, and a growing requirement forlocal trials in the pharmaceutical approval process. Despite this, we note that the majority of clinical trialswill continue to take place in developed countries.

Headline Expenditure Projections

- Pharmaceuticals: From EUR5.83bn (USD7.81bn) in 2014 to EUR5.85bn (USD6.43bn) in 2015; 0.33%in local currency terms and -17.6% in US dollar terms.

- Healthcare: From EUR43.86bn (USD58.77bn) in 2014 to EUR44.96bn (USD49.46bn) 2015; +2.5% inlocal currency terms and -15.9% in US dollar terms.

Table Of Contents

Belgium Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Belgium 2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Belgium 2011-2019) 12
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Belgium 2011-2019) 14
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Belgium 2011-2019) 15
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Belgium 2011-2019) 15
Prescription Drug Market Forecast 16
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Belgium 2011-2019) 17
Patented Drug Market Forecast 18
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Belgium 2011-2019) 19
Belgium 20
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Belgium 2011-2019) 22
OTC Medicine Market Forecast 23
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Belgium 2011-2019) 24
Pharmaceutical Trade Forecast 25
Table: Pharmaceutical Trade Data And Forecasts (Belgium 2013-2019) 26
Table: Pharmaceutical Trade Data And Forecasts local currency (Belgium 2013-2019) 27
Industry Risk Reward Index 28
Western Europe Risk/Reward Index 28
Belgium Risk/Reward Index 34
Rewards 34
Risks 34
Regulatory Review 36
Intellectual Property Issues 37
Pricing Regime 38
Reimbursement Regime 40
Table: Reimbursements by Category, 2009 42
Table: Price Build-Up for OTC Medicines 44
Market Overview 45
Healthcare Sector 45
Table: Healthcare Resources (Belgium 2009-2014) 47
Table: Healthcare Personnel (Belgium 2009-2014) 47
Table: Healthcare Activity (Belgium 2009-2014) 48
Research and Development 50
Clinical Trials 50
Epidemiology 52
Competitive Landscape 54
Research-Based Industry 54
Table: Multinational Market Activity 55
Pharmaceutical Distribution 57
Pharmaceutical Retail Sector 57
Company Profile 59
Galapagos 59
Janssen Pharmaceutica 62
UCB Pharma 65
Demographic Forecast 69
Table: Population Headline Indicators (Belgium 1990-2025) 70
Table: Key Population Ratios (Belgium 1990-2025) 70
Table: Urban/Rural Population and Life Expectancy (Belgium 1990-2025) 71
Table: Population By Age Group (Belgium 1990-2025) 71
Table: Population By Age Group % (Belgium 1990-2025) 72
Glossary 74
Methodology 76
Pharmaceutical Expenditure Forecast Model 76
Healthcare Expenditure Forecast Model 76
Notes On Methodology 77
Risk/Reward Index Methodology 78
Index Overview 79
Table: Pharmaceutical Risk/Reward Index Indicators 79
Indicator Weightings 80

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.